[LGND] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
12-Dec-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- 2,267.17%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 108,973 71,914 64,538 48,974 31,388 30,037 23,538 29.06%
PBT 7,960 35,329 11,302 9,207 -3,865 -2,930 -15,403 -
Tax 10,327 -219,596 410 374 -1,191 -13,103 -2,617 -
NP -1,636 257,305 12,024 11,421 -527 10,176 -12,515 -28.73%
Tax Rate -129.74% 621.57% -3.63% -4.06% - - - -
Total Cost 110,609 -185,391 52,514 37,553 31,915 19,861 36,053 20.52%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -1.50 357.80 18.63 23.32 -1.68 33.88 -53.17 -44.79%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -0.08 13.00 0.59 0.56 -0.03 0.52 -0.64 -29.26%
EPS Diluted -0.08 12.12 0.56 0.55 -0.03 0.52 -0.64 -29.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.